Myrtelle
Business Services · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
17 State St Fl 3, New York City, New Yor...Website
www.myrtellegtx.comRevenue
$5.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Myrtelle
Myrtelle, Inc. is a gene therapy company focused on transforming the treatment of neurological diseases, particularly myelin-based disorders such as leukodystrophies. The company aims to improve the quality of life for patients with rare neurological disorders by developing innovative therapeutic approaches. Myrtelle's proprietary technologies allow for the treatment of various diseases involving white matter, and they engage in strategic partnerships to enhance their research and development efforts. Their mission is to provide effective treatment options for patients who currently have limited or no alternatives.Explore more
Myrtelle Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Myrtelle your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Myrtelle is spiking on competitors!
Check if Myrtelle has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Myrtelle launches new products
Funding: Get notified immidiatlly once Myrtelle has new funding data
Myrtelle, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Myrtelle
Earning: See what the market has to say on Myrtelle recently announced quarterly report
Click to see if Myrtelle had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Myrtelle
Compare insights from companies similar to Myrtelle, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Myrtelle is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Myrtelle is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Myrtelle.
Myrtelle Tech Stack
A closer look at the technologies used by Myrtelle
See more technologies
Myrtelle News & Media
Myrtelle Announces Presentation of Encouraging Interim Results from its Phase 1/2 Gene Therapy Trial for Canavan Disease at the 2025 Cell & Gene Meeting on the Mesa
NEW YORK, Oct. 6, 2025 /PRNewswire/ -- Myrtelle Inc. ("Myrtelle" or the "Company"), a gene therapy company pioneering transformative treatments for neurodegenerative diseases, today announced that Dr. Michael Muhonen, M.D., Co-Chief Medical Officer, will present an overview of the Company...Myrtelle Announces Nature Medicine Publication of Interim Results from Its Phase 1/2 Clinical Trial of Investigational Gene Therapy rAAV-Olig001-ASPA for Canavan Disease
Groundbreaking study demonstrates that targeted oligodendrocyte gene therapy leads to decreased N-acetylaspartate (NAA) levels and increased brain myelin.Myrtelle Announces Nature Medicine Publication of Interim Results from Its Phase 1/2 Clinical Trial of Investigational Gene Therapy rAAV-Olig001-ASPA for Canavan Disease
Groundbreaking study demonstrates that targeted oligodendrocyte gene therapy leads to decreased N-acetylaspartate (NAA) levels and increased brain myelin volume, resulting in promising functional improvements in children with Canavan Disease NEW YORK, Sept. 16, 2025 /PRNewswire/ --...Myrtelle Launches Manufacturing of First-in-Class Gene Therapy for Canavan Disease in Strategic Alliance with Charles River and Viralgen
Team prepares for commercialization bolstered by START Program and regulatory recognition NEW YORK, July 8, 2025 /PRNewswire/ -- Myrtelle Inc. ("Myrtelle" or the "Company"), a pioneering clinical-stage gene therapy company dedicated to revolutionizing treatment for neurodegenerative...
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Myrtelle
Sign Up For FreeTo access detailed company insights
Myrtelle, Inc. is a gene therapy company focused on transforming the treatment of neurological diseases, particularly myelin-based disorders such as leukodystrophies. The company aims to improve the quality of life for patients with rare neurological disorders by developing innovative therapeutic approaches. Myrtelle's proprietary technologies allo... Read More
